Group 1 (The Intervention Group) for Pain

Phase-Based Progress Estimates
MD Anderson Cancer Center, Houston, TX
Pain+4 More
The Intervention Group - Other
All Sexes
What conditions do you have?

Study Summary

To learn if using guided imagery and deep breathing techniques can help with pain management in patients who have post-mastectomy pain syndrome.

Eligible Conditions

  • Pain
  • Syndrome Pain
  • Symptom Management

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: through study completion, an average of 1 year

Year 1
The change in pain severity score and the change in pain interference score, measured by brief pain inventory short form. Brief Pain Inventory: 0-10 No Pain-0 Worst Pain-10

Trial Safety

Trial Design

2 Treatment Groups

Group 1 (The Intervention Group)
1 of 2
Group 2 ( The Control Group)
1 of 2
Experimental Treatment

62 Total Participants · 2 Treatment Groups

Primary Treatment: Group 1 (The Intervention Group) · No Placebo Group · N/A

Group 1 (The Intervention Group)
Experimental Group · 1 Intervention: The Intervention Group · Intervention Types: Other
Group 2 ( The Control Group)
Experimental Group · 1 Intervention: The Control Group · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year
Closest Location: MD Anderson Cancer Center · Houston, TX
Photo of MD Anderson Cancer Center  1Photo of MD Anderson Cancer Center  2Photo of MD Anderson Cancer Center  3
2004First Recorded Clinical Trial
1 TrialsResearching Pain
520 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have pain intensity of 5-10 on the baseline pain severity score or pain interference score of 5-10.
You must understand and read English, sign a written informed consent, and follow protocol requirements.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.